Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Cells|April 13, 2026
VPS34 in Autophagy, Cancer, and Cancer TherapyElisabetta Bartolini, Bassam Janji, Ruize GaoOncoimmunology|June 14, 2024
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34Elisabetta Bartolini, Kris Van Moer, Bassam JanjiAutophagy Reports|May 21, 2025
Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapyElisabetta Bartolini, Kris Van Moer, Bassam JanjiFrontiers in Immunology|July 7, 2022
The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?Bassam Janji, Salem ChouaibOncoimmunology|September 16, 2021
"Suffocating" tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapyBassam Janji, Salem ChouaibOncoimmunology|April 18, 2025
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse modelMuhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao, et al.Oncoimmunology|December 5, 2022
A role for EMT in CD73 regulation in breast cancerMeriem Hasmim, Guy Berchem, Bassam JanjiFrontiers in Immunology|June 21, 2018
Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor ImmunityBassam Janji, Guy Berchem, Salem ChouaibOncotarget|February 16, 2017
Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progressionMassimo Giuliani, Bassam Janji, Guy BerchemAutophagy|January 26, 2018
Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefieldMuhammad Zaeem Noman, Guy Berchem, Bassam JanjiPageof 12